OPRX

OptimizeRx Corporation

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$10.0k30-Sep-2610-Q filed 13-Nov-26
Remaining authorization$10.0kEST30-Sep-2610-Q filed 13-Nov-26
Program expiry15-Mar-2730-Sep-2610-Q filed 13-Nov-26
Repurchased last quarterNot found in filings—
Has used an ASRNo—

Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.

Programs

Authorized onAuthorizedRemainingExpiresTerms
05-Mar-26$10.0k$10.0kEST15-Mar-27On March 5, 2026, the Company announced that its Board authorized the repurchase of up to $10,000 of the Company’s outstanding common stock.10-Q filed 13-Nov-26

Open-market repurchases

None reported in the filings we hold.

Filings through 30-Sep-26· checked 17-Nov-26